Hubei Cancer Hospital
Clinical trials sponsored by Hubei Cancer Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Blood tests may predict flap complications in breast reconstruction Results expected Sep 2026 (estimated)
- Double-Target immunotherapy added to standard care for aggressive cervical cancer Results expected Dec 2026 (estimated)
- Gut bacteria could be key to stopping cancer Drug's diarrhea side effect Results expected Jun 2027 (estimated)
- Nipple fluid DNA test could spare thousands from unnecessary breast surgery Results expected Jun 2027 (estimated)